Retour sur lavenir.net
   UCB 231.200 € (+2,21 %)     MELEXIS 71.350 € (+5,70 %)     AEDIFICA 71.850 € (+0,98 %)     KBC 113.250 € (-0,09 %)     ARGENX SE 668.000 € (+1,83 %)     AGEAS 66.700 € (+0,23 %)     EVS BROADC.EQUIPM. 37.500 € (+1,63 %)     AB INBEV 64.400 € (+2,88 %)     GIMV 48.000 € (+0,42 %)     AZELIS GROUP 11.280 € (+1,90 %)     ONTEX GROUP 2.910 € (+0,17 %)     BARCO 9.525 € (+0,90 %)     CARE PROPERTY INV. 12.940 € (+0,94 %)     PROXIMUS 6.510 € (+0,46 %)     CFE 11.350 € (+1,79 %)     SIPEF 101.600 € (+2,32 %)     RETAIL ESTATES 67.900 € (+1,04 %)     DEME GROUP 194.000 € (+3,85 %)     ONWARD MEDICAL 2.660 € (+0,38 %)     BREDERODE 103.000 € (+0,59 %)     TITAN S.A. 46.120 € (+0,48 %)     BEKAERT 41.950 € (+0,84 %)     CAMPINE 220.000 € (+2,33 %)     NEXTENSA 46.945 € (+0,42 %)     HOME INVEST BE. 19.200 € (-0,52 %)     RECTICEL 10.100 € (+1,61 %)     NYXOAH 2.530 € (+1,20 %)     BIOTALYS 3.000 € (+1,87 %)     TINC 12.020 € (+0,67 %)     ELIA GROUP 141.400 € (+2,39 %)     JENSEN-GROUP 68.600 € (-0,58 %)     SHURGARD 26.200 € (+1,16 %)     ASCENCIO 49.850 € (+0,71 %)     SYENSQO 56.350 € (+1,53 %)     SOFINA 218.000 € (+1,02 %)     BANQUP GROUP 2.450 € (-2,00 %)     COLRUYT 32.840 € (-0,48 %)     VIOHALCO 14.600 € (-2,01 %)     FAGRON 24.000 € (0,00 %)     ORANGE BELGIUM 21.000 € (0,00 %)     FLUXYS BELGIUM D 21.800 € (0,00 %)     XIOR 27.600 € (+0,91 %)     IBA 13.380 € (-0,45 %)     EXMAR 10.800 € (+1,89 %)     VAN DE VELDE 32.700 € (+0,31 %)     ECONOCOM GROUP 1.415 € (-2,41 %)     KINEPOLIS GROUP 30.600 € (-0,16 %)     DECEUNINCK 2.140 € (-0,70 %)     TUBIZE-FIN 195.700 € (+2,19 %)     CMB.TECH 11.620 € (+2,11 %)     CIE BOIS SAUVAGE 334.000 € (+3,09 %)     ACKERMANS V.HAAREN 280.200 € (+1,74 %)     KBC ANCORA 77.700 € (0,00 %)     BPOST 1.810 € (+1,46 %)     LOTUS BAKERIES 10 260.000 € (+1,18 %)     VGP 87.300 € (+0,23 %)     D'IETEREN GROUP 175.600 € (+0,46 %)     SOLVAC NOM(RETAIL) 75.000 € (-0,66 %)     GBL 79.500 € (+0,82 %)     IMMOBEL 22.100 € (+5,74 %)  
   CAPGEMINI 103.000 € (+0,29 %)     HYDROGEN REFUELING 1.470 € (-6,73 %)     PHILIPS KON 22.390 € (+2,14 %)     KLARSEN 0.548 € (+83,89 %)     BOIRON 27.400 € (+4,58 %)     PROLOGUE 0.254 € (+0,79 %)     STMICROELECTRONICS 46.015 € (+2,90 %)     KERING 232.650 € (+0,04 %)     TETRAGON FIN GRP 13.300 € (-2,21 %)     SOITEC 126.950 € (+12,25 %)     VEOLIA ENVIRON. 35.940 € (+3,25 %)     PAULIC MEUNERIE 1.580 € (+11,27 %)     MAGNUM 12.440 € (+11,45 %)     ING GROEP N.V. 24.755 € (+3,66 %)     POSTNL 0.948 € (+0,69 %)     GASCOGNE 2.360 € (+9,26 %)     VALLOUREC 25.650 € (+2,35 %)     CIECHARGEURSINVEST 8.440 € (-2,54 %)     AIRBUS 174.880 € (+0,15 %)     ASML HOLDING 1 222.400 € (+2,50 %)     PROSUS 41.070 € (+1,03 %)     LVMH 451.400 € (+0,66 %)     SHELL PLC 38.510 € (+1,80 %)     VINCI 128.500 € (+1,86 %)     IMCD 100.150 € (+3,01 %)     CVC CAPITAL 12.950 € (+3,52 %)     FDJ UNITED 23.100 € (-1,53 %)     TECHNIP ENERGIES 40.300 € (-0,05 %)     E PANGO 0.190 € (-23,08 %)     ALSTOM 17.080 € (+4,27 %)     AMUNDI 82.200 € (+1,29 %)     ASR NEDERLAND 64.560 € (+0,91 %)     TOTALENERGIES 79.290 € (+1,35 %)     SARTORIUS STED BIO 156.700 € (+3,43 %)     EXOR NV 66.800 € (+0,91 %)     CARMILA 16.980 € (-0,12 %)     NEXANS 158.100 € (+3,27 %)     SAINT GOBAIN 77.640 € (+1,54 %)     SOCIETE GENERALE 68.440 € (-3,59 %)     BE SEMICONDUCTOR 247.200 € (+3,26 %)     DANONE 66.740 € (+0,97 %)     BUREAU VERITAS 26.060 € (+0,81 %)     EXAIL TECHNOLOGIES 123.600 € (-0,24 %)     HEINEKEN HOLDING 60.400 € (+1,85 %)     ASM INTERNATIONAL 830.600 € (+2,57 %)     ARKEMA 62.000 € (+1,06 %)     COVIVIO 56.200 € (+0,54 %)     IPSEN 167.000 € (+2,52 %)     SANOFI 79.820 € (+1,92 %)     LEGRAND 151.800 € (+1,57 %)     AHOLD DEL 40.020 € (+0,58 %)     FUGRO 12.350 € (+7,11 %)     GECINA 71.850 € (+0,42 %)     FRANCAISE ENERGIE 38.000 € (-0,91 %)     STELLANTIS NV 6.215 € (-6,40 %)     NN GROUP 74.300 € (+0,92 %)     KAUFMAN ET BROAD 27.650 € (+0,55 %)     ISPD 1.740 € (0,00 %)     EKINOPS 2.490 € (-2,92 %)     MYHOTELMATCH 0.174 € (-1,14 %)  
News Réglementées
02/05/2026 00:00

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration

VANCOUVER, BC / ACCESS Newswire / May 1, 2026 / Redwood AI Corp. (CSE:AIRX)(OTCQB:RDWCF)(Frankfurt:Y0N, WKN: A422EZ) ("Redwood" or the "Company") is pleased to announce preliminary results from a research initiative, conducted in collaboration with Professor Jolene Reid at the University of British Columbia ("UBC"), aimed at enhancing Reactosphere (the "Platform"), the Company's AI-driven chemical synthesis platform. The initiative has produced new models designed to complement Redwood's conventional AI models, expanding the platform's evaluated chemical reaction universe from approximately 4 million training examples to more than 21 million examples, a 425% increase. Redwood believes these early results are important because they point toward a more advanced synthesis platform that could give clients stronger predictive insight, and a better ability to assess synthetic routes before committing time and resources in the lab.

Traditional AI models used in chemical synthesis are often highly effective at recognizing patterns in historical reaction data, but they do not necessarily understand the chemistry that drives how and why reactions occur. Redwood's upgraded approach is intended to address that limitation by introducing models that better interpret the sequence of chemical events that can take place as reactants are transformed into products. Preliminary findings indicate that these new datasets have learnable patterns and preliminary results demonstrate promising accuracy. This matters because a more principled system can provide insight beyond route prediction alone. By better understanding how a reaction may proceed, Redwood believes Reactosphere could eventually help chemists identify not only promising synthetic routes, but also potential side reactions and unwanted by-products, which remain a major challenge in chemical development and process scale-up. The Company believes this capability could improve decision-making across a broad range of chemistry applications and enhance the usefulness of AI-assisted synthesis planning for pharmaceutical, biotech, and chemical industry clients.

The research initiative is supported in part with the Mitacs Accelerate program. Mitacs is a national innovation organization that drives industry-academic collaboration, deploys skilled talent, and builds innovation capacity in Canada.1 Through programs such as Accelerate, Mitacs supports research-based collaborations among post-secondary researchers, industry partners, and academic supervisors to help solve complex challenges and advance new ideas.2

"The preliminary results from this project are highly encouraging because they suggest we can extend Reactosphere beyond pattern recognition toward a platform with deeper predictive intelligence. By combining the principled models with our existing AI systems, we believe we can improve the quality of synthesis planning, and create new opportunities to help clients better understand route feasibility and potential by-products," said Louis Dron, CEO of Redwood AI.

About Redwood AI Corp.

Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defence and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI's platform enables faster, more efficient development of new therapies and chemistry-driven applications.

ON BEHALF OF REDWOOD AI CORP.,

"Louis Dron"
Chief Executive Officer

For more information, please contact:
Louis Dron
Chief Executive Officer
Tel: +1 888 530 8488
investors@redwoodai.com

The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.

Forward-Looking Statements Caution. This news release contains statements and information that, to the extent they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information is generally identified by words such as "believe", "expect", "anticipate", "estimate", "intend", "plan", "may", "should", "will", "potential" and similar expressions and, in this news release, includes statements relating to the perceived enhancements made to the Platform, and the potential for an increase in accuracy and the potential for new use cases as a result thereof, the development and potential deployment of the AI-powered Platform generally, and to the business plans of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on it, as actual results may differ materially from those expressed or implied. Forward-looking information inherently involves risks and uncertainties, many of which are beyond the Company's control. The forward-looking information contained in this news release is made as of the date hereof, and the Company undertakes no obligation to publicly update or revise such information, whether as a result of new information, future events or otherwise, except as required by applicable laws.



View the original press release on ACCESS Newswire

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière